Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.380
+0.070 (2.11%)
At close: Jul 21, 2026, 4:00 PM EDT
3.262
-0.118 (-3.49%)
After-hours: Jul 21, 2026, 4:55 PM EDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $7.31 million as of July 21, 2026. Its market cap has decreased by -48.58% in one year.
Market Cap
7.31M
Enterprise Value
-1.53M
1-Year Change
-48.58%
Ranking
Category
Stock Price
$3.38
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $7.31M, a decrease of -60.45%. That is a compound annual growth rate of -5.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 7.31M | -70.32% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 7.52M |
| Jupiter Neurosciences | 7.12M |
| Kairos Pharma | 6.85M |
| PharmaCyte Biotech | 6.76M |
| Xenetic Biosciences | 6.71M |
| Acurx Pharmaceuticals | 6.53M |
| Ernexa Therapeutics | 6.50M |
| XTL Biopharmaceuticals | 6.47M |